key articles
9th ESOU key messages: experts express caution on unvalidated imaging techniques
Friday, 20 April 2012- The validity of emerging diagnostic imaging techniques for prostate cancer such as functional magnetic resonance imaging (MRI) were challenged and closely examined today, with some experts pointing...
By Joel Vega
9th ESOU Meeting re-examines prostate cancer issues on screening, biopsies and imaging
Friday, 19 April 2012- The issue of prostate cancer screening remains a much-discussed topic but recent studies are proving that screening decreases prostate cancer mortality, according to J. Hugosson who lectured during the...
By Joel Vega
Personalized peptide vaccination for castration-resistant prostate cancer patients
Thursday, 19 April 2012- Docetaxel-based chemotherapy (DBC) showed limited clinical efficacy for castration-resistant prostate cancer (CRPC) patients. M. Noguchi and colleagues aimed to explore cancer vaccine as a new treatment...
Filed by: JV
8-year experience with focal cryotherapy in men with unilateral low-intermediate risk PCa
Friday, 23 March 2012- The goal of focal therapy for localised prostate cancer is long-term cancer control, while decreasing functional morbidity.
O. Ukimura and colleagues conducted a study to report an 8-year experience of...
Posted by: JV
Patterns of PCa on template prostate mapping biopsies in 291 men: Implications for focal therapy
Friday, 16 March 2012- Template Prostate Mapping (TPM) biopsies using a 5mm sampling frame is the most accurate and appropriate test to localise clinically significant prostate cancer in men seeking focal therapy. H. U....
Filed by: JV
GPIU study shows infective complications after prostate biopsy
Thursday, 8 March 2012- Infective complications after prostate biopsy is becoming a worldwide health problem, according to a multinational, multicenter study whose findings were released during the abstract session on prostate...
By Joel Vega
Phase IIIb CS30 trial on degarelix meets primary goal
Monday, 5 March 2012- Degarelix is ‘non-inferior’ to the combination of goserelin plus bicalutamide at reducing prostate volume in patients with advanced hormone-dependent prostate cancer, according to the main conclusion of the...
By Evgenia Starkova
Robot-assisted radical prostatectomy patients more likely to be dissatisfied with post-surgical outcomes
Monday, 20 February 2012- In a previous study F. Schroeck and colleagues found that patients undergoing robotic assisted laparoscopic radical prostatectomy vs radical retropubic prostatectomy had a higher likelihood of not being...
Edited by: JV
Goserelin versus leuprolide in the chemical castration of prostate cancer patients
Friday, 17 February 2012- E. Dias Silvia conducted a study to evaluate the relative efficiency of leuprolide 3.75 mg, leuprolide 7.5 mg, and goserelin 3.6 mg in relation to the reduction in serum testosterone, regarding the...
Edited by: JV
Milk and dairy consumption in men with prostate cancer and metastases risk
Friday, 10 February 2012- Whether milk and dairy intake after a prostate cancer diagnosis is associated with a poorer prognosis is unknown.
A. Pettersson and colleagues investigated post-diagnostic milk and dairy intake in...
Edited by: JV
